3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Neoplasms
11
Breast Neoplasms
8
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Pancreatic cancer, adult
2
Ovarian Neoplasms
2
Lymphoma
2
Disease
2
Carcinoma, Hepatocellular
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Stroke
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Retroviridae Infections
1
Renal Insufficiency
1
Prostate Cancer Metastatic
1
Pancreatic carcinoma, familial
1
Pancreatic Neoplasms
1
Ovarian Germ Cell Cancer
1
Oligomenorrhea
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Cells, Circulating
1
Interventions
Sorafenib
20
lenvatinib
18
Hepatectomy
17
Blood Specimen Collection
12
Immune Checkpoint Inhibitors
11
atezolizumab
9
Liver Transplantation
9
Surgical Procedures, Operative
7
Radiofrequency Ablation
7
Observation
7
Bevacizumab
7
regorafenib
5
gadolinium ethoxybenzyl DTPA
5
sintilimab
4
donafenib
4
camrelizumab
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
tislelizumab
3
spartalizumab
3
Polymerase Chain Reaction
3
Neoadjuvant Therapy
3
Mass Spectrometry
3
Immunohistochemistry
3
Doxorubicin
3
Angiogenesis Inhibitors
3
toripalimab
2
pembrolizumab
2
entecavir
2
apatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Hepatocellular
×
Hematologic Tests
×
Clear all
NCT06717295
2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
6,000 enrolled
NCT03852238
2019-02-25
NoFlic
University Hospital, Bordeaux
Completed
283 enrolled